141 related articles for article (PubMed ID: 23117985)
1. Neurotropic infectious agents and cognitive impairment in schizophrenia.
Nimgaonkar VL; Yolken RH
Schizophr Bull; 2012 Nov; 38(6):1135-6. PubMed ID: 23117985
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii and cognitive deficits in schizophrenia: an animal model perspective.
Kannan G; Pletnikov MV
Schizophr Bull; 2012 Nov; 38(6):1155-61. PubMed ID: 22941742
[TBL] [Abstract][Full Text] [Related]
3. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.
Prasad KM; Watson AM; Dickerson FB; Yolken RH; Nimgaonkar VL
Schizophr Bull; 2012 Nov; 38(6):1137-48. PubMed ID: 22490995
[TBL] [Abstract][Full Text] [Related]
4. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
Hamdani N; Daban-Huard C; Godin O; Laouamri H; Jamain S; Attiba D; Delavest M; Lépine JP; Le Corvoisier P; Houenou J; Richard JR; Yolken RH; Krishnamoorthy R; Tamouza R; Leboyer M; Dickerson FB
J Clin Psychiatry; 2017 Jan; 78(1):e18-e27. PubMed ID: 27929612
[TBL] [Abstract][Full Text] [Related]
6. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.
Yolken RH; Torrey EF; Lieberman JA; Yang S; Dickerson FB
Schizophr Res; 2011 May; 128(1-3):61-5. PubMed ID: 21353483
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.
Bamne M; Wood J; Chowdari K; Watson AM; Celik C; Mansour H; Klei L; Gur RC; Bradford LD; Calkins ME; Santos AB; Edwards N; Kwentus J; McEvoy JP; Allen TB; Savage RM; Nasrallah HA; Gur RE; Perry RT; Go RC; Devlin B; Yolken R; Nimgaonkar VL
Schizophr Bull; 2012 Nov; 38(6):1149-54. PubMed ID: 22966150
[TBL] [Abstract][Full Text] [Related]
8. Persistent infection with neurotropic herpes viruses and cognitive impairment.
Watson AM; Prasad KM; Klei L; Wood JA; Yolken RH; Gur RC; Bradford LD; Calkins ME; Richard J; Edwards N; Savage RM; Allen TB; Kwentus J; McEvoy JP; Santos AB; Wiener HW; Go RC; Perry RT; Nasrallah HA; Gur RE; Devlin B; Nimgaonkar VL
Psychol Med; 2013 May; 43(5):1023-31. PubMed ID: 22975221
[TBL] [Abstract][Full Text] [Related]
9. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.
Prasad KM; Eack SM; Keshavan MS; Yolken RH; Iyengar S; Nimgaonkar VL
Schizophr Bull; 2013 Jul; 39(4):857-66. PubMed ID: 22446565
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia and toxoplasmosis.
Torrey EF; Yolken RH
Schizophr Bull; 2007 May; 33(3):727-8. PubMed ID: 17426051
[No Abstract] [Full Text] [Related]
11. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
[TBL] [Abstract][Full Text] [Related]
13. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia.
Schretlen DJ; Vannorsdall TD; Winicki JM; Mushtaq Y; Hikida T; Sawa A; Yolken RH; Dickerson FB; Cascella NG
Schizophr Res; 2010 May; 118(1-3):224-31. PubMed ID: 20153952
[TBL] [Abstract][Full Text] [Related]
14. The known and missing links between Toxoplasma gondii and schizophrenia.
Elsheikha HM; Büsselberg D; Zhu XQ
Metab Brain Dis; 2016 Aug; 31(4):749-59. PubMed ID: 27041387
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to infectious agents in individuals with recent onset schizophrenia.
Leweke FM; Gerth CW; Koethe D; Klosterkötter J; Ruslanova I; Krivogorsky B; Torrey EF; Yolken RH
Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):4-8. PubMed ID: 14991372
[TBL] [Abstract][Full Text] [Related]
16. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
[TBL] [Abstract][Full Text] [Related]
17. Herpes Simplex Virus Type-1 Infection: Associations with Inflammation and Cognitive Aging in Relation to Schizophrenia.
Nimgaonkar VL; Bhatia T; Mansour A; Wesesky MA; Deshpande S
Curr Top Behav Neurosci; 2020; 44():125-139. PubMed ID: 31049838
[TBL] [Abstract][Full Text] [Related]
18. Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia.
Holub D; Flegr J; Dragomirecká E; Rodriguez M; Preiss M; Novák T; Čermák J; Horáček J; Kodym P; Libiger J; Höschl C; Motlová LB
Acta Psychiatr Scand; 2013 Mar; 127(3):227-38. PubMed ID: 23126494
[TBL] [Abstract][Full Text] [Related]
19. The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.
Fruchter E; Goldberg S; Fenchel D; Grotto I; Ginat K; Weiser M
Schizophr Res; 2015 Oct; 168(1-2):292-6. PubMed ID: 26362735
[TBL] [Abstract][Full Text] [Related]
20. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Ruslanova I; Yolken RH
Arch Gen Psychiatry; 2003 May; 60(5):466-72. PubMed ID: 12742867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
